Multiple myeloma trials in Netherlands

In Netherlands 33 Also abroad 704

33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
Where
Maastricht, Nieuwegein, Rotterdam
Age
18 years and over
People
105 worldwide
Run by
European Myeloma Network B.V.
See details and how to join2023-505775-70-00 · EU 2023-505775-70-00
Phase 3Not yet taking people in Netherlands
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
Where
Leiden, Rotterdam
Age
18 years and over
People
520 worldwide
Run by
AbbVie
See details and how to joinNCT07728188 · EU 2026-525596-11-00
Phase 1Taking people
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Where
Amsterdam, Rotterdam, Utrecht
Age
18 years and over
People
135 worldwide
Run by
AbbVie
See details and how to joinNCT06896916 · EU 2024-512146-41-00
Phase 3Not yet taking people in Netherlands
A study investigating the safety and efficacy of academically-produced CAR T cells compared with standard treatment for patients with multiple myeloma whose disease has returned or not responded to previous treatments.
Where
Groningen
Age
18 years and over
People
126
Run by
Universitair Medisch Centrum Groningen
See details and how to join2025-524876-43-00 · EU 2025-524876-43-00
Phase 2Taking people
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
Where
Amsterdam, Arnhem, Enschede, Geleen, Groningen, Nieuwegein, Rotterdam, 's-Gravenhage, Zwolle
Age
18 years and over
People
150 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT07107529 · EU 2024-520433-76-00
Phase 3Taking people
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Where
Rotterdam
Age
18 years and over
People
1,000 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00
Phase 1/2Taking people
LUMC-BOB1-B7-TCR.1 in relapsed and refractory B-cell malignancies
Where
Leiden
Age
18 years and over
People
22
Run by
Leids Universitair Medisch Centrum (LUMC)
See details and how to join2024-515900-38-00 · EU 2024-515900-38-00
Phase 3Taking people
FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
Where
Alkmaar, Almelo, Almere, Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Arnhem, Assen, Beugen, Beverwijk, Breda, Capelle aan den IJssel, Delft, Deventer, Dirksland, Doetinchem, Dordrecht, Drachten, Ede Gld, Eindhoven, Emmen, Enschede, Geldrop, Geleen, Goes, Gorinchem, Gouda, Groningen, Hardenberg, Harderwijk, Heerenveen, Helmond, Hilversum, Hoofddorp, Hoorn Nh, Leeuwarden, Leiderdorp, Maastricht, Nieuwegein, Nijmegen, Roermond, Roosendaal, Rotterdam, Scheemda, Schiedam, 's-Gravenhage, 's-Hertogenbosch, Sneek, Terneuzen, Tiel, Tilburg, Uden, Utrecht, Venlo, Zaandam, Zwolle, St. Jans Gasthuis
Age
18 years and over
People
599
Run by
Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06187441 · EU 2023-508586-33-00